EE160 Tepotinib for the Treatment of Adult Patients with Metastatic Non-Small Cell Lung Cancer Harboring METEX14 Skipping Alterations: A US Cost-Effectiveness Analysis
Abstract
Authors
M Yang R Sachdev M Stargardter J Tosh H Vioix